Drugplain

Hydralazine 25 mg/1

HYDRALAZINE HYDROCHLORIDE · TABLET · Nivagen Pharmaceuticals, Inc.

10 Recalls on Record
Plain English

Hydralazine is a tablet containing hydralazine hydrochloride at 25 mg/1, taken oral. Manufactured by Nivagen Pharmaceuticals, Inc..

Key Facts

Brand Name
Hydralazine
Generic Name
HYDRALAZINE HYDROCHLORIDE
NDC Code (Product)
75834-126
Manufacturer
Nivagen Pharmaceuticals, Inc.
Strength
25 mg/1
Dosage Form
TABLET
Route
ORAL
Marketing Status
Application #
ANDA203845
Marketing Start
02/15/2017

Recall History

10 Recalls on Record
Class III11/05/2024

The Harvard Drug Group LLC dba Major Pharmaceuticals and Rugby Laboratories

Failed Impurities/Degradation Specifications; during routine stability testing for impurities.

TerminatedVoluntary: Firm initiated
Class II03/08/2017

Mckesson Medical Surgical

Temperature Abuse: Certain pieces of these lots distributed by McKesson Medical Surgical Inc. were inadvertently stored refrigerated rather than the labeled room temperature recommendation.

TerminatedVoluntary: Firm initiated
Class III07/28/2015

Fresenius Kabi USA, LLC

Incorrect Expiration Date: The "11/06" expiration date printed on the tray (secondary packaging) is incorrect (it should be 11/2016)

TerminatedVoluntary: Firm initiated
Class III09/01/2023

Amerisource Health Services LLC

Failed Impurities/Degradation Specifications: Out of Specification results in the repackaged product for impurities at the 12-month time point.

TerminatedVoluntary: Firm initiated
Class II07/02/2013

Aidapak Services, LLC

Labeling: Label Mixup; HYDRALAZINE HCL Tablet, 25 mg may be potentially mislabeled as DOCUSATE CALCIUM, Capsule, 240 mg, NDC 00536375501, Pedigree: AD49582_16, EXP: 5/16/2014.

TerminatedVoluntary: Firm initiated
Class II01/26/2022

CARDINAL HEALTHCARE

CGMP Deviations: Products were exposed to temperatures outside of the products labeled storage conditions.

TerminatedVoluntary: Firm initiated
Class II04/26/2023

Akorn, Inc.

CGMP Deviations: Firm went out of business and could no longer continue stability studies.

OngoingVoluntary: Firm initiated
Class II02/09/2024

The Harvard Drug Group LLC dba Major Pharmaceuticals and Rugby Laboratories

an out of specification result obtained during routine stability testing for Impurities. There is a remote possibility that use of this product could cause a medically reversible or transient adverse health consequences.

TerminatedVoluntary: Firm initiated
Class II12/18/2013

Teva Pharmaceuticals USA

Failed Impurities/Degradation Specifications:There is a potential for the tablets to be out of specification for impurities throughout shelf life.

TerminatedVoluntary: Firm initiated
Class II07/02/2013

Aidapak Services, LLC

Labeling: Label Mixup; hydrALAZINE HCl Tablet, 50 mg may be potentially mislabeled as CapsuleTOPRIL, Tablet, 12.5 mg, NDC 00143117101, Pedigree: AD52778_16, EXP: 5/20/2014.

TerminatedVoluntary: Firm initiated

Frequently Asked Questions

What is Hydralazine used for?

Hydralazine contains HYDRALAZINE HYDROCHLORIDE. It is a tablet taken oral. Consult your doctor for specific uses.

Is Hydralazine a controlled substance?

Hydralazine is not classified as a controlled substance by the DEA.

What is the generic name for Hydralazine?

The generic name for Hydralazine is HYDRALAZINE HYDROCHLORIDE. There are 11 other brand versions of HYDRALAZINE HYDROCHLORIDE.

What is the NDC code for Hydralazine 25 mg/1?

The NDC (National Drug Code) for Hydralazine 25 mg/1 is 75834-126, listed by Nivagen Pharmaceuticals, Inc..